Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors

作者：Hampson Robert E; Sweatt Andrew J; Goonawardena Anushka V; Song Dong; Chan Rosa H M; Marmarelis Vasilis Z; Berger Theodore W; Deadwyler Sam A^*

来源：Behavioural Pharmacology, 2011, 22(4): 335-346.

DOI：10.1097/FBP.0b013e3283473bfd

• cannabinoids
• hippocampal ensembles
• endocannabinoids
• intrahippocampal infusion
• memory encoding
• patterned stimulation
• rat

It has previously been demonstrated that the detrimental effect on the performance of a delayed nonmatch to sample (DNMS) memory task by exogenously administered cannabinoid (CB1) receptor agonist, WIN 55212-2 (WIN), is reversed by the receptor antagonist rimonabant. In addition, rimonabant administered alone elevates DNMS performance, presumably through the suppression of negative modulation by released endocannabinoids during normal task performance. Other investigations have shown that rimonabant enhances encoding of DNMS task-relevant information on a trial-by-trial, delay-dependent basis. In this study, these reciprocal pharmacological actions were completely characterized by long-term, chronic intrahippocampal infusion of both agents (WIN and rimonabant) in successive 2-week intervals. Such long-term exposure allowed extraction and confirmation of task-related firing patterns, in which rimonabant reversed the effects of CB1 agonists. This information was then utilized to artificially impose the facilitatory effects of rimonabant and to reverse the effects of WIN on DNMS performance, by delivering multichannel electrical stimulation in the same firing patterns to the same hippocampal regions. Direct comparison of normal and WIN-injected subjects, in which rimonabant injections and ensemble firing facilitated performance, verified reversal of the modulation of hippocampal memory processes by CB1 receptor agonists, including released endocannabinoids.

• 出版日期2011-8